Synonyms 葡糖苷酰鞘氨醇 |
Introduction- |
Target |
Mechanism Glucosylceramidase replacements |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date26 Feb 2010 |
Target |
Mechanism Glucosylceramidase replacements [+1] |
Active Org. M6P TherapeuticsStartup |
Originator Org. M6P TherapeuticsStartup |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism Glucosylceramidase replacements |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date15 Nov 2023 |
Sponsor / Collaborator- |
Start Date01 Oct 2023 |
Sponsor / Collaborator |
Start Date03 Jan 2023 |
Sponsor / Collaborator |